Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;12(3):275–286. doi: 10.1111/j.1750-3639.2002.tb00442.x

Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice

Oliver Wirths 1, Gerd Multhaup 4, Christian Czech 2, Nicole Feldmann 1, Véronique Blanchard 2, Günter Tremp 3, Konrad Beyreuther 4, Laurent Pradier 2, Thomas A Bayer 1,✉
PMCID: PMC8095864  PMID: 12146796

Abstract

Neuropil deposition of β‐amyloid peptides Aβ40 and Aβ42 is believed to be the key event in the neurodegenerative processes of Alzheimer's disease (AD). Since Aβ seems to carry a transport signal that is required for axonal sorting of its precursor β‐amyloid precursor protein (APP), we studied the intraneuronal staining profile of Aβ peptides in a transgenic mouse model expressing human mutant APP751 (KM670/671NL and V717I) and human mutant presenilin‐1 (PS‐1 M146L) in neurons. Using surface plasmon resonance we analyzed the Aβ antibodies and defined their binding profile to APP, Aβ40 and Aβ42. Immunohistochemical staining revealed that intraneuronal Aβ40 and Aβ42 staining preceded plaque deposition, which started at 3 months of age. Aβ was observed in the somatodendritic and axonal compartments of many neurons. Interestingly, the striatum, which lacks transgenic APP expression harbored many plaques at 10 months of age. This is most likely due to an APP/Aβ transport problem and may be a model region to study APP/Aβ trafficking as an early pathological event.

Full Text

The Full Text of this article is available as a PDF (736.5 KB).

References

  • 1. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Alzheimer's Disease Collaborative Group. (1995) Nat Genet 11:219–222. [DOI] [PubMed] [Google Scholar]
  • 2. Allsop D, Haga SI, Haga C, Ikeda SI, Mann DM, Ishii T (1989) Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol 15:531–542. [DOI] [PubMed] [Google Scholar]
  • 3. Bayer TA, Fossgreen A, Czech C, Beyreuther K, Wiestler OD (1996) Plaque formation in brain transplants exposed to human beta‐amyloid precursor protein 695. Acta Neuropathol (Berl) 92:130–137. [DOI] [PubMed] [Google Scholar]
  • 4. Bayer TA, Wirths O, Majtenyi K, Hartmann T, Multhaup G, Beyreuther K, Czech C (2001) Key factors in Alzheimer's disease: beta‐amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 11:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Beher D, Hesse L, Masters CL, Multhaup G (1996) Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J Biol Chem 271:1613–1620. [DOI] [PubMed] [Google Scholar]
  • 6. Borchelt DR, Ratovitski T, Van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939–945. [DOI] [PubMed] [Google Scholar]
  • 7. Buxbaum JD, Greengard P (1996) Regulation of APP processing by intra‐ and intercellular signals. Ann N Y Acad Sci 777:327–331. [DOI] [PubMed] [Google Scholar]
  • 8. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S et al (2001) Early‐onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276:21562–21570. [DOI] [PubMed] [Google Scholar]
  • 9. Cook DG, Forman MS, Sung JC, Leight S, Kolson DL, Iwatsubo T, Lee VM, Doms RW (1997) Alzheimer's A beta(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med 3:1021–1023. [DOI] [PubMed] [Google Scholar]
  • 10. Czech C, Delaere P, Macq AF, Reibaud M, Dreisler S, Touchet N, Schombert B, Mazadier M, Mercken L, Theisen M, Pradier L et al (1997) Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Brain Res Mol Brain Res 47:108–116. [DOI] [PubMed] [Google Scholar]
  • 11. De Strooper B, Annaert W (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113:1857–1870. [DOI] [PubMed] [Google Scholar]
  • 12. Dewachter I, Van Dorpe J, Smeijers L, Gilis M, Kuiperi C, Laenen I, Caluwaerts N, Moechars D, Checler F, Vanderstichele H, Van Leuven F (2000) Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1. J Neurosci 20:6452–6458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Dodart JC, Mathis C, Ungerer A (2000) The beta‐amyloid precursor protein and its derivatives: from biology to learning and memory processes. Rev Neurosci 11:75–93. [DOI] [PubMed] [Google Scholar]
  • 14. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez‐tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D et al (1996) Increased amyloid‐beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710–713. [DOI] [PubMed] [Google Scholar]
  • 15. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T et al (1995) Alzheimer‐type neuropathology in transgenic mice overexpressing V717F beta‐amyloid precursor protein. Nature 373:523–527. [DOI] [PubMed] [Google Scholar]
  • 16. Glenner GG, Wong CW (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovasular amyloid protein. Biochem Biophys Res Commun 120:885–890. [DOI] [PubMed] [Google Scholar]
  • 17. Glenner GG, Wong CW, Quaranta V, Eanes ED (1984) The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol 2:357–369. [PubMed] [Google Scholar]
  • 18. Goate A, Chartier‐Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L. et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704–706. [DOI] [PubMed] [Google Scholar]
  • 19. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, Sisodia SS, Greengard P, Xu H (1999) Endoplasmic reticulum and trans‐Golgi network generate distinct populations of Alzheimer beta‐amyloid peptides. Proc Natl Acad Sci U S A 96:742–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC (2001) Intraneuronal abeta‐amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125:489–492. [DOI] [PubMed] [Google Scholar]
  • 22. Haass C, Schlossmacher MG, Hung AY, Vigo Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid beta‐peptide is produced by cultured cells during normal metabolism. Nature 359:322–325. [DOI] [PubMed] [Google Scholar]
  • 23. Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med 3:1016–1020. [DOI] [PubMed] [Google Scholar]
  • 24. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer‐type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97–100. [DOI] [PubMed] [Google Scholar]
  • 25. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L (1999) Plaque‐independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 96:3228–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D et al (1995) Age related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203–1218. [DOI] [PubMed] [Google Scholar]
  • 27. Ida N, Hartmann T, Pantel J, Schröder J, Zerfass R, Förstl H, Sandbrink R, Masters CL, Beyreuther K (1996) Analysis of heterogeneous βA4 peptides in human cererbrospinal fluid and blood by a newly‐developed sensitive Western blot assay. J Biol Chem 271:22908–22914. [DOI] [PubMed] [Google Scholar]
  • 28. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end‐ specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13:45–53. [DOI] [PubMed] [Google Scholar]
  • 29. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller‐Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733–736. [DOI] [PubMed] [Google Scholar]
  • 30. Kim SH, Leem JY, Lah JJ, Slunt HH, Levey AI, Thinakaran G, Sisodia SS (2001) Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J Biol Chem 276:43343–43350. [DOI] [PubMed] [Google Scholar]
  • 31. Kosik KS, Qiu WQ, Greenberg S (1996) Cellular signaling pathways and cytoskeletal organization. Ann N Y Acad Sci 777:114–120. [DOI] [PubMed] [Google Scholar]
  • 32. LaFerla FM, Troncoso JC, Strickland DK, Kawas CH, Jay G (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J Clin Invest 100:310–320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid beta‐peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3:16–32. [DOI] [PubMed] [Google Scholar]
  • 34. Leutner S, Czech C, Schindowski K, Touchet N, Eckert A, Muller WE (2000) Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin‐1 with single or multiple mutations. Neurosci Lett 292:87–90. [DOI] [PubMed] [Google Scholar]
  • 35. Levy‐Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K. et al (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973–977. [DOI] [PubMed] [Google Scholar]
  • 36. Luthi A, Putten H, Botteri FM, Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schroder M, Nitsch C, Laurent JP, Monard D (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long‐term potentiation. J Neurosci 17:4688–4699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245–4249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, Yu X, Uljon S, Wang R, Mann D, Dickson D, Duff K (1999) Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 6:231–244. [DOI] [PubMed] [Google Scholar]
  • 39. Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483–6492. [DOI] [PubMed] [Google Scholar]
  • 40. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F (1996) Expression in brain of amyloid precursor protein mutated in the alpha‐ secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. Embo J 15:1265–1274. [PMC free article] [PubMed] [Google Scholar]
  • 41. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N‐terminus of beta‐amyloid. Nat Genet 1:345–347. [DOI] [PubMed] [Google Scholar]
  • 42. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ, Chen X, Stokin GB, Koo EH (1999) Mutagenesis identifies new signals for beta‐amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 274:18851–18856. [DOI] [PubMed] [Google Scholar]
  • 43. Probst A, Langui D, Ipsen S, Robakis N, Ulrich J (1991) Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol (Berl) 83:21–29. [DOI] [PubMed] [Google Scholar]
  • 44. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T. et al (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775–778. [DOI] [PubMed] [Google Scholar]
  • 45. Scheuermann S, Hambsch B, Hesse L, Stumm J, Schmidt C, Beher D, Bayer TA, Beyreuther K, Multhaup G (2001) Homodimerization of APP and its implication in the amyloidogenic pathway of Alzheimers disease. J Biol Chem 276:33923–33929. [DOI] [PubMed] [Google Scholar]
  • 46. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy‐Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid b‐protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2:864–870. [DOI] [PubMed] [Google Scholar]
  • 47. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23–31. [DOI] [PubMed] [Google Scholar]
  • 48. Selkoe DJ, Yamazaki T, Citron M, Podlisny MB, Koo EH, Teplow DB, Haass C (1996) The role of APP processing and trafficking pathways in the formation of amyloid beta‐protein. Ann N Y Acad Sci 777:57–64. [DOI] [PubMed] [Google Scholar]
  • 49. Sheetz MP, Pfister KK, Bulinski JC, Cotman CW (1998) Mechanisms of trafficking in axons and dendrites: implications for development and neurodegeneration. Prog Neurobiol 55:577–594. [DOI] [PubMed] [Google Scholar]
  • 50. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K. et al (1995) Cloning of a gene bearing missense mutations in early‐onset familial Alzheimer's disease. Nature 375:754–760. [DOI] [PubMed] [Google Scholar]
  • 51. Simons M, Ikonen E, Tienari PJ, Cid‐Arregui A, Monning U, Beyreuther K, Dotti CG (1995) Intracellular routing of human amyloid protein precursor: axonal delivery followed by transport to the dendrites. J Neurosci Res 41:121–128. [DOI] [PubMed] [Google Scholar]
  • 52. Sinha S, Lieberburg I (1999) Cellular mechanisms of beta‐amyloid production and secretion. Proc Natl Acad Sci U S A 96:11049–11053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Skovronsky DM, Doms RW, Lee VM (1998) Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J Cell Biol 141:1031–1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Sturchler‐Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease‐like pathology. Proc Natl Acad Sci U S A 94:13287–13292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, George‐Hyslop PH St., Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) The amyloid β protein gene: cDNA cloning, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880–884. [DOI] [PubMed] [Google Scholar]
  • 56. Tienari PJ, De Strooper B, Ikonen E, Ida N, Simons M, Masters CL, Dotti CG, Beyreuther K (1996) Neuronal sorting and processing of amyloid precursor protein: implications for Alzheimer's disease. Cold Spring Harb Symp Quant Biol 61:575–585. [PubMed] [Google Scholar]
  • 57. Tienari PJ, De Strooper B, Ikonen E, Simons M, Weidemann A, Czech C, Hartmann T, Ida N, Multhaup G, Masters CL, Van Leuven F, Beyreuther K, Dotti CG (1996) The β‐amyloid domain is essential for axonal sorting of amyloid precursor protein. EMBO J 15:5218–5229. [PMC free article] [PubMed] [Google Scholar]
  • 58. Wertkin AM, Turner RS, Pleasure SJ, Golde TE, Younkin SG, Trojanowski JQ, Lee VM (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695‐amino acid amyloid precursor protein and produce intracellular beta‐amyloid or A4 peptides. Proc Natl Acad Sci U S A 90:9513–9517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Wild‐Bode C, Yamazaki T, Capell A, Leimer U, Steiner H, Ihara Y, Haass C (1997) Intracellular generation and accumulation of amyloid beta‐peptide terminating at amino acid 42. J Biol Chem 272:16085–16088. [DOI] [PubMed] [Google Scholar]
  • 60. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA (2001) Intra‐neuronal Abeta accumulation precedes plaque formation in beta‐amyloid precursor protein and presenilin‐1 double‐transgenic mice. Neurosci Lett 306:116–120. [DOI] [PubMed] [Google Scholar]
  • 61. Xu H, Sweeney D, Wang R, Thinakaran G, Lo AC, Sisodia SS, Greengard P, Gandy S (1997) Generation of Alzheimer beta‐amyloid protein in the trans‐Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci U S A 94:3748–3752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Yang AJ, Chandswangbhuvana D, Shu T, Henschen A, Glabe CG (1999) Intracellular accumulation of insoluble, newly synthesized abeta‐42 in amyloid precursor protein‐transfected cells that have been treated with Abeta1‐42. J Biol Chem 274:20650–20656. [DOI] [PubMed] [Google Scholar]
  • 63. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, Rogaeva E, Xu D, Liang Y, Duthie M, George‐Hyslop PH St, Fraser PE (1998) The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta‐catenin. J Biol Chem 273:16470–16475. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES